OCUGEN, INC. Other Current Liabilities
OCUGEN, INC. (OCGN) had Other Current Liabilities of $9.76 thousand as of 2020-12-31, per its 10-K filed 2021-03-19.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2021-03-19
- 2020-12-31: Other Liabilities, Current $9.76K.
- 2020-09-30: Other Liabilities, Current $199.26K.
- 2020-06-30: Other Liabilities, Current $204.86K.
- 2020-03-31: Other Liabilities, Current $206.41K.
| Period end | Other Liabilities, Current |
|---|---|
| 2020-12-31 | $9.76K 10-K · filed 2021-03-19 |
| 2020-09-30 | $199.26K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $204.86K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $206.41K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $205.99K 10-K · filed 2021-03-19 |
| 2018-12-31 | $204.24K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |